1. Home
  2. III vs ORGO Comparison

III vs ORGO Comparison

Compare III & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Information Services Group Inc.

III

Information Services Group Inc.

N/A

Current Price

$5.74

Market Cap

197.1M

ML Signal

N/A

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

N/A

Current Price

$1.40

Market Cap

181.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
III
ORGO
Founded
2006
1985
Country
United States
United States
Employees
1500
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
197.1M
181.4M
IPO Year
2006
2016

Fundamental Metrics

Financial Performance
Metric
III
ORGO
Price
$5.74
$1.40
Analyst Decision
Buy
Hold
Analyst Count
2
2
Target Price
★ $6.80
$2.00
AVG Volume (30 Days)
185.0K
★ 534.3K
Earning Date
11-02-2026
11-05-2026
Dividend Yield
★ 3.25%
N/A
EPS Growth
216.67
★ 1600.00
EPS
★ 0.12
N/A
Revenue
$192,745,000.00
★ $564,169,000.00
Revenue This Year
$4.24
N/A
Revenue Next Year
$3.59
$37.55
P/E Ratio
$45.00
★ N/A
Revenue Growth
4.51
★ 17.04
52 Week Low
$3.74
$1.34
52 Week High
$6.45
$7.08

Technical Indicators

Market Signals
Indicator
III
ORGO
Relative Strength Index (RSI) 70.83 31.90
Support Level $5.47 $1.34
Resistance Level $6.11 $2.55
Average True Range (ATR) 0.15 0.06
MACD 0.01 0.01
Stochastic Oscillator 98.06 17.65

Price Performance

Historical Comparison
III
ORGO

About III Information Services Group Inc.

Information Services Group Inc is an AI-centered technology research and advisory firm providing digital transformation and technology advisory services that help organizations optimize performance, reduce costs, and accelerate innovation. The Company's expertise includes sourcing advisory, cloud and data analytics, managed governance and risk services, network and software advisory, technology strategy and operations design, change management, and market intelligence, serving both private- and public-sector clients globally. It operates in one segment, fact-based sourcing advisory services, and operates principally in the Americas, with generate maximum revenue in Europe and the Asia Pacific.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: